4-Methylmorpholine → 3-Dimethylamino-1-[[(1H)-indol 3 yl]carbonyl]piperidine
反応式
Cl.Cl.[CH3:3][N:4]([CH3:11])[CH:5]1[CH2:10][CH2:9][CH2:8][NH:7][CH2:6]1.CN1CCOCC1.[NH:19]1[C:27]2[C:22](=[CH:23][CH:24]=[CH:25][CH:26]=2)[C:21]([C:28](O)=[O:29])=[CH:20]1.C1(N=C=NC2CCCCC2)CCCCC1.C(O)(=O)/C=C\C(O)=O>C(O)(C)C.CCOCC.ClCCl>[CH3:3][N:4]([CH3:11])[CH:5]1[CH2:10][CH2:9][CH2:8][N:7]([C:28]([C:21]2[C:22]3[C:27](=[CH:26][CH:25]=[CH:24][CH:23]=3)[NH:19][CH:20]=2)=[O:29])[CH2:6]1参加物
反応物 5
生成物 1
試薬・触媒・溶媒 3
実験手順
A mixture of 3-dimethylaminopiperidine dihydrochloride (1.8 g, 0.01 mol), N-methylmorpholine (2.5 g) and dichloromethane (50 ml) was stirred at ambient temperature for 1.5 h. Indole-3-carboxylic acid (1.92 g, 0.012 mol) was added, followed by dicyclohexylcarbodiimide (2.5 g) and the mixture stirred for 24 h. The mixture was filtered, the filtrate was washed thrice with 1M hydrochloric acid, the acid washings were combined, basified with ammonia and extracted with chloroform. The chloroform extract was dried and evaporated to yield the product base 1.6 g. The base was dissolved in isopropyl alcohol (20ml), acidified with maleic acid (0.72 g, 5% excess) and diluted with ether (10 ml). On standing the maleate salt crystallised and was collected by filtration, 1.04 g, mp 139-141.
後処理
- stirringthe mixture stirred for 24 h
- filtrationThe mixture was filtered
- washthe filtrate was washed thrice with 1M hydrochloric acid
- extractionextracted with chloroform
- extractionThe chloroform extract
- customwas dried
- customevaporated
- customto yield the product base 1.6 g
- customcrystallised
- filtrationwas collected by filtration, 1.04 g, mp 139-141
出典と根拠
- ORDレコード
- ord-fbf17b3555e84a708d574706ac6ea66c
- 出典データセット
- uspto-grants-1990_09
- 特許番号
- US04959375
反応ノート
読み込み中…